Showing results (311-320 of 383) with videos related to

Sort By:
Pageof 39
Communications Biology|August 8, 2020
Genetically detoxified pertussis toxin displays near identical structure to its wild-type and exhibits robust immunogenicitySalvador F Ausar, Shaolong Zhu, Jessica Duprez, et al.
Therapeutic Drug Monitoring|June 4, 2016
Therapeutic Drug Monitoring, Electronic Health Records, and Pharmacokinetic Modeling to Evaluate Sirolimus Drug Exposure-Response Relationships in Renal Transplant PatientsKanecia O Zimmerman, Huali Wu, Rachel Greenberg, et al.
Therapeutic Drug Monitoring|October 21, 2016
Use of Therapeutic Drug Monitoring, Electronic Health Record Data, and Pharmacokinetic Modeling to Determine the Therapeutic Index of Phenytoin and LamotrigineLawrence C Ku, Huali Wu, Rachel G Greenberg, et al.
The Pediatric Infectious Disease Journal|June 20, 2024
Postdiscontinuation Antibiotic Exposure in Hospitalized Infants at Risk for Late-onset Sepsis in the Neonatal Intensive Care UnitKelly C Wade, Rachel G Greenberg, Daniel K Benjamin, et al.
Physical Review Letters|February 9, 2005
Competing magnetic phases on a kagomé staircaseG Lawes, M Kenzelmann, N Rogado, et al.
Current Protocols|February 28, 2026
Mass Cytometry Workflow to Achieve High-Dimensional Immunophenotyping in Resource-Limited or Decentralized EnvironmentsNatalie Smith, Michael Cohen, Lauren Tracey, et al.
Clinical Pharmacokinetics|October 7, 2021
Development and Evaluation of a Virtual Population of Children with Obesity for Physiologically Based Pharmacokinetic ModelingJacqueline G Gerhart, Fernando O Carreño, Andrea N Edginton, et al.
Antimicrobial Agents and Chemotherapy|March 27, 2019
Rifampin Pharmacokinetics and Safety in Preterm and Term InfantsP Brian Smith, C Michael Cotten, Mark L Hudak, et al.
Antimicrobial Agents and Chemotherapy|September 13, 2017
External Evaluation of Two Fluconazole Infant Population Pharmacokinetic ModelsMichael F Hwang, Ryan J Beechinor, Kelly C Wade, et al.
The Pediatric Infectious Disease Journal|April 17, 2013
Determining population and developmental pharmacokinetics of metronidazole using plasma and dried blood spot samples from premature infantsMichael Cohen-Wolkowiez, Mario Sampson, Barry T Bloom, et al.
Pageof 39